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Abstract
Background: Many pregnant women gain excess weight during pregnancy which increases the health risks to the
mother and her baby. Interventions to prevent excess weight gain need to be given to the whole population to
prevent excess weight gain. The aim of this study was to assess the effectiveness of a simple and brief intervention
embedded withinroutine antenatal care to prevent excessive gestation weight gain.
Methods: Six hundred and ten pregnant women (between 10-14 weeks gestation), aged ≥18 years with a body
mass index (BMI) ≥18.5 kg/m2, planned to receive community midwife led care or shared care at the time of
recruitment are eligible to take part in the study. Women will be recruited from four maternity centres in England.
Community midwives complete a short training module before delivering the intervention. In the intervention,
midwives weigh women, set maximum weight limits for weight gain at each antenatal appointment and ask
women to monitor their weight at home. Themaximum weight limit is adjusted by the midwife at each antenatal
appointment if women have exceeded their maximum weight gain limit set at their previous appointment. The
intervention will be compared with usual antenatal care. The primary outcome is the proportion of women per
group who exceed the Institute of Medicine guidelines for gestational weight gain at 38 weeks of pregnancy
according to their early pregnancy BMI category.
Discussion: The proposed trial will test a brief intervention comprising regular weighing, target setting and
monitoring ofweight during pregnancy that can be delivered at scale as part of routine antenatal care. Using the
professional expertise of community midwives, but without specialist training in weight management, the
intervention will incur minimal additionalhealthcare costs, and if effective at reducing excess weight gain, is likely to
be very cost effective.
Trial registration: Current controlled trials ISRCTN67427351. Date assigned 29/10/2014.
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Background
Pregnancy is a critical risk period for the development of
later obesity [1]. Average weight gain in pregnancy has
increased dramatically in the last two decades and this is
true for women across body mass index (BMI) categories
[2, 3]. Most pregnant women in developed and develop-
ing countries exceed current USA Institute of Medicine
(IOM) or similar guidance [4–7]. The IOM recommend
that women with a healthy, overweight and obese pre
pregnancy BMI should gain between 11.5–16 kg, 7–
11.5 kg and 5–9 kg respectively. Although some coun-
tries monitor pregnant women to assess whether they
are gaining appropriate weight, many do not, including
the UK. Excessive gestational weight gain is associated
with several adverse maternal and infant outcomes that
could be prevented with better weight control, such as
gestational diabetes, pre-eclampsia, delivery complica-
tions, caesarean sections, macrosomia and stillbirth
[1, 8, 9]. Excess gestational weight gain is associated
with postnatal weight retention up to 10–15 years
after pregnancy in all BMI categories of women [10–14].
The weight women gain during pregnancy but fail to lose
after pregnancy leads to incremental gains across suc-
cessive pregnancies [12]. In addition, studies report an
association between high maternal weight gain during
pregnancy and increased adiposity and morbidity in chil-
dren [15, 16].
Women often feel that gaining weight during preg-
nancy is inevitable and weight control is less important
than at other life stages [17–19]. Studies have reported a
lack of awareness amongst pregnant women about the
risks of excessive gestational weight gain and many
women reduce their physical activity and consume a
more liberal diet when pregnant [20, 21]. There have
been calls for weight management to be formally inte-
grated into routine antenatal care in the UK and other
countries but there is a paucity of evidence of effective
interventions to prevent excessive gestational weight
gain. Studies have reported that pregnant women feel
health professionals should support and guide them
about weight gain during pregnancy and that midwives
are the most appropriate people to do so [22]. Community
midwives have regular contact with women throughout
pregnancy, providing multiple opportunities for them to
intervene and this is consistent with their role to promote
good outcomes for mother and baby. Yet weight manage-
ment is not seen as a priority, nor is weight routinely
monitored in the UK or many other countries [23] Studies
show that women believe that if gestational weight gain
was important their midwife would have discussed it with
them [17], which may lead many pregnant women to con-
clude it is not a health risk to them or their baby if their
weight is not discussed and/or monitored. Most rando-
mised controlled trials (RCTs) to date have focussed on
specialist interventions for obese women who are preg-
nant. This is important, but the majority of women who
become pregnant are healthy or overweight, not obese, yet
pregnancy may be the time when weight control slips and
preventative interventions are needed for these women to
minimise their long-term health risks and potential ad-
verse effects on their baby.
Evidence
Numerous recent systematic reviews [24–37] have assessed
the effectiveness of weight management interventions dur-
ing pregnancy. One of these [24] reviews showed an over-
all reduction in weight gain −0.97 kg in those randomised
to weight management programmes compared with con-
trols. For dietary based interventions the effect was larger
at −3.36 kg. Analysis showed that dietary interventions re-
sulted in significant reductions in preeclampsia, dystocia,
gestational hypertension and pre term birth. Whilst the
many systematic reviews to date have all had different in-
clusion and exclusion criteria, without exception, they have
concluded there are insufficient high quality trials to judge
the effectiveness of interventions to promote healthy ges-
tational weight gain, with several reviews highlighting this
as a particular omission in women who are not already
obese. Moreover, trials to date have evaluated very inten-
sive and costly interventions in obese pregnant women
and there is a paucity of trials focused on preventing ex-
cessive gestational weight gain in all pregnant women.
Previous relevant trials
A feasibility trial conducted in Finland provided evi-
dence that involving midwives in delivery of weight
control interventions is feasible [38]. It embedded an in-
tensive diet and physical activity counselling intervention
delivered by public health nurses (similar to community
midwives) to low risk pregnant women. The intervention
was found feasible to implement; the average participa-
tion rate of eligible women was 77 % and drop out was
low at 15 %. An RCT enrolled 236 pregnant women of
any BMI [39]. It evaluated an intervention where women
were asked by a medical student researcher at 12 weeks
gestation to weigh themselves and to plot their weight
on a chart during pregnancy with no support thereafter,
providing additional information that this type of inter-
vention is feasible to implement. Compared to usual care
however the intervention was not effective in preventing
excessive weight gain. This could be because community
midwives were not involved in reinforcing this message
during pregnancy or checking the woman’s chart and
providing feedback. Nor were key components of self-
regulation such as goal setting and feedback included.
There have been trials that have demonstrated effect-
ive interventions that prevented excessive weight gain,
but they have not been embedded in routine care. The
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recent FeLIPO trial (n = 250) conducted in Germany
assessed the efficacy of an intervention to prevent exces-
sive weight gain in women with a BMI ≥18.5 kg [40].
The intervention consisted of two individually delivered
counselling sessions led by specialist staff focussing on
diet, physical activity and weight monitoring lasting 60
and 30 min respectively and delivered at 20 and 30 weeks
of pregnancy. The intervention led to a substantially
lower proportion of women exceeding the IOM guide-
lines for gestational weight gain compared with the con-
trol group (38 % versus 60 %). An RCT conducted in the
USA randomised women (n = 120) to usual care or a
multi component behavioural intervention involving
consultations with a researcher and dietician about
healthy lifestyle behaviours, mailed prompts, encourage-
ment of self monitoring of physical activity and energy
intake, free weighing scales to encourage regular self
monitoring and personalised feedback on weight gain
[41]. Compared with standard care the intervention de-
creased the proportion of women of baseline healthy
BMI who exceeded the IOM guidelines for gestational
weight gain (40.2 % versus 52.1 %). These studies show
that interventions can be effective in reducing excess
weight gain among a general sample of pregnant women,
but they require specialist staff and are more intensive
and expensive than could be offered as part of routine
antenatal care for all pregnant women. For primary and
secondary prevention, low intensity and cost efficient in-
terventions that can be given to all pregnant women are
required; one approach that would meet these criteria is
regular weighing, target setting and monitoring of weight
during pregnancy delivered using the existing professional
expertise of community midwives, rather than specialists
in weight management.
Target setting for healthy weight gain, regular weighing
and feedback
There has been growing interest in the possibility of rou-
tine weighing of women during pregnancy in the UK but
the National Institute for Health and Care Excellence
(NICE) [42] concluded that the evidence base was insuf-
ficient to make recommendations, reinforcing the need
for new research now. The potential efficacy of regular
weighing and target setting (either by the individual or
someone else, such as a health professional) is based on
the principles of self regulation theory [43, 44]. Self regu-
lation has been described as a process that has three dis-
tinct stages; self monitoring, self evaluation and self
reinforcement. Self monitoring is a method of systematic
self observation, periodic measurement and recording of
target behaviours with the goal of increasing self aware-
ness. The awareness fostered during self monitoring is
considered an essential initial step in promoting and
sustaining behaviour change. Our own work in non
pregnant populations and other studies [45–47] have
showed that regular weighing can facilitate weight con-
trol; similar interventions during pregnancy, a time of
dynamic weight change, may also have merit. However,
even if regular weighing helps women control their
weight during pregnancy, concerns have been expressed
that it may have negative psychological consequences
and that feedback about body size may result in anxiety,
or lead to the adoption of unhealthy weight control prac-
tices during pregnancy. In non pregnant women however
there is no evidence to support these concerns [48, 49].
Feasibility work: Preventing Obesity in Pregnancy Study
(POPS)
In preparation for this phase III trial we conducted a
feasibility RCT with 76 pregnant women randomised to
usual antenatal care only or usual antenatal care plus an
intervention involving community midwives setting tar-
gets for healthy weight gain, regular weighing and pro-
viding feedback on progress. The intervention was
delivered by eight community midwives who weighed
women in their care, plotted their weight on a persona-
lised BMI specific IOM weight gain chart, gave feedback
on progress according to the weight chart (see Fig. 1)
and set a maximum weight gain limit for women at each
antenatal appointment. The weight target was adjusted
at each appointment if women had exceeded their weight
gain target set at the previous appointment (Fig. 2a–c).
Targets were always for weight gain even if maximum rec-
ommended weight gain had already been exceeded.
Women were given a weight record chart and asked to
weigh themselves weekly between appointments to check
their own weight gain (see Fig. 3).
We developed a training module for midwives to de-
liver the intervention. We also looked for evidence of
intervention contamination in the usual care group. We
obtained feedback through semi structured interviews
from midwives about their experiences of implementing
the intervention within routine care. More detail about
the feasibility study and the results has been published
elsewhere [50]. In summary, the intervention proved
feasible to deliver and was considered acceptable by preg-
nant women and community midwives. Data showed a
modest but promising difference favouring the interven-
tion group in the percentage of women exceeding the
IOM recommended weight gain for their early BMI cat-
egory (23.5 % versus 29.4 %) at 38 weeks of pregnancy.
The trial was not planned to be large enough to estimate
the difference in the proportion achieving healthy weight
gain as this is the purpose of a definitive effectiveness trial.
There was no evidence the intervention caused undue
anxiety in the intervention group relative to usual care. In
the usual care group we found no evidence of intervention
contamination where midwives gave the intervention to
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this group. The intervention group reported higher total
physical activity scores at 38 weeks of pregnancy than
usual care. The intervention group also reported participa-
tion in substantially more vigorous intensity physical activ-
ity (double the rate) than usual care at 38 weeks gestation.
Views of community midwives: feasibility study
Most midwives commented that they had had some initial
apprehension about delivering the intervention because it
was something new, but that over time it became second
nature. All the midwives felt it was feasible to deliver the
intervention within the context of routine antenatal care,
taking on average about one to two minutes per appoint-
ment, which was not perceived as adding substantially to
their workload. Midwives liked the intervention because it
was simple to do. Midwives felt the weight gain chart pro-
vided them with a legitimate opportunity or ‘excuse’ to
raise the topic of gestational weight gain.
Fig. 1 Example weight gain chart
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Views of pregnant women: feasibility study
Twelve intervention participants were interviewed 6–8
weeks postnatally. Women reported the main reason
that they liked the intervention was that it might help
them avoid gaining too much weight during pregnancy.
Women particularly liked being weighed at each ap-
pointment because it provided on-going motivation to
consider their lifestyle choices. Women felt the interven-
tion was useful in helping them to be more aware and
vigilant about their eating and physical activity and they
appreciated having a target weight set by the midwife.
Women did not have any concerns about discussing
their weight with their midwife and the majority felt that
regular weighing during pregnancy was important and
worthwhile and some had recommended self-weighing
to others. Most of the women interviewed weighed
themselves each week between antenatal appointments,
but only a few recorded this on their record chart,
highlighting that additional strategies to encourage this
behaviour will be needed in the phase III trial.
Fig. 2 a: Example of how to set weight gain limits for antenatal
appointments. The woman is recruited at 12 weeks gestation and her
weight is plotted on the chart for this week of pregnancy. The woman
is advised that her weight should follow the dotted line drawn
through the ideal weight gain zone on the chart (unshaded area). The
woman is due to be seen again by her midwife at 16 weeks gestation
therefore the midwife draws a vertical line at 16 weeks gestation to
meet the dashed line in the unshaded ideal weight gain zone to
ascertain what the maximum weight target should be for 16 weeks
gestation. In this example the woman is advised by her midwife that
ideally her weight should be no more than 63.5 kg at 16 weeks
gestation. The midwife repeats the procedure at each antenatal
appointment. b: Example of how to set weight gain limits for antenatal
appointments. At 16 weeks of pregnancy the midwife weighed the
woman and plotted her weight on the chart. In this example the
woman weighed 63.5 is 16 weeks gestation which was the maximum
weight limit set at her previous appointment at 12 weeks gestation.
The midwife then set the maximum weight target for the next
antenatal appointments which was scheduled for 25 weeks gestation.
The midwife draws a vertical line at 25 weeks of gestation to meet the
dashed line in the unshaded ideal weight gain zone to ascertain what
the maximum weight target should be for 25 weeks gestation. In this
example the woman should ideally weigh no more than 67 kg at 16
weeks gestation. c: How to set and adjust maximum weight targets if
women gain too much weight. At 25 weeks gestation the midwife
weighed the woman and plotted her weight, which was 70 kg. This
was above the maximum weight target set at the previous
appointment at 16 weeks gestation. The midwife therefore redraws the
ideal weight trajectory line starting from the plotted weight at 25
weeks gestation to the central point in the unshaded weight zone
until 42 weeks gestation. The midwife uses this new line to set the
maximum weight target for the next antenatal appointment scheduled
for 28 weeks gestation. The midwife draws a vertical line at 28 weeks
of gestation to meet the dashed line in the unshaded ideal weight
gain zone to ascertain what the maximum weight target should be for
28 weeks gestation. The midwife advised the woman that her
maximum weight target for 28 weeks of pregnancy was 70.6 kg
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Methods
Primary objective
 To assess the effectiveness of a brief intervention to
encourage healthy weight gain during pregnancy.
Secondary objectives
 To assess the difference in weight gain per weeks of
pregnancy between the groups.
 To compare the difference in change in total weight
gain during pregnancy between the groups.
 To compare the difference in changes in
psychological health, physical activity and diet
quality between the groups.
 To compare the occurrence rates of common
complications of pregnancy (e.g. c-section,
hypertension in pregnancy and gestational diabetes)
between the groups.
Study design
This study is a two group RCT with participants allo-
cated to receive usual antenatal care only or usual ante-
natal care plus the intervention. Participants will be
individually randomised to the trial groups. See Fig. 4
for trial flow
Outcome measures
The primary outcome is the proportion of participants
per group who exceed the IOM guidelines for gesta-
tional weight gain according to their early pregnancy
BMI category from baseline to 38 weeks of pregnancy.
Secondary outcomes are the difference in weight gain
per weeks of pregnancy between the groups, difference
in total weight from baseline to 38 weeks of pregnancy
between the groups and difference in changes in psycho-
logical health, physical activity and diet quality between
the groups from baseline to 38 weeks of pregnancy.
Identification and recruitment of pregnant women
Women will receive the participant information leaflet
from their community midwife at their first antenatal
appointment or by post. Women will be advised to read
the leaflet and that they may be approached to partici-
pate in the study after they have had their dating scan at
10 –14 weeks of pregnancy.
Eligible women who do not consent
The researcher at the scan clinics will record the num-
ber of women each day who are eligible but do not pro-
vide consent to participate when approached. With the
verbal consent of the woman the researcher making the
approach will log the BMI status, ethnicity and age of
eligible women approached who do not consent to par-
ticipate in the study.
Recruitment
This trial is multisite with participants recruited from
four maternity centres in the UK; Birmingham Women’s
NHS Foundation Trust, The Dudley Group NHS Foun-
dation Trust, Oxford University Hospitals NHS Trust
(OUH) and South Warwickshire NHS Foundation Trust
where there are 7670, 4610, 6500 and 3456 births per
year respectively (total yearly births 22,236). Of these
97 % (n = 21,568) will be of either healthy weight, over-
weight or obese at booking, and of these we conservatively
expect 55 % to be confirmed as receiving community
midwife led care (n = 12,230) and fully eligible, dem-
onstrating there is a very large population available
from which we can recruit. We plan to enrol 610
pregnant women.
Fig. 3 Weight record card
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Sample size
We will recruit 610 participants, with 305 randomised to
each group.
Planned inclusion criteria
 Aged 18 years or more
 Between 10+0 and 14+6 weeks of pregnancy
 Singleton pregnancy with a BMI ≥18.5 kg/m2 at the
time of recruitment planned to receive community
midwife led care or shared care where it is
anticipated any consultant appointments will be in
addition to community midwife appointments, at
the time of recruitment. This criteria is included
because it is important that women enrolled into the
study who are randomised to the intervention group
receive all the intervention contacts with their
community midwife.
Planned exclusion criteria
 Women referred for consultant led care where it is
anticipated that midwife appointments will be
substituted by consultant appointments
 Unable to understand English or provide informed
consent
 Women who are attending a weight management
programme (i.e. Slimming World Whilst Pregnant)
 Current severe mental illness, known history of eating
disorders or dependent on illicit drugs or alcohol
Women subsequently confirmed as eligible at scan (10-14 weeks) recruited by 
research team. Weight measured (baseline weight).
Objective measurement of weight at 38 weeks of pregnancy by community midwives and outcome 
questionnaires completed by post
Women given participant information leaflet by community midwife or received by 
post prior to their scan at 10-14 weeks of pregnancy
Usual care plus Intervention 
At each antenatal appointment community midwives:
a. Weigh women
b. Plot weight and give feedback on progress
c. Set maximum weight limit for each subsequent 
appointment
d. Give brief advice on healthy eating and encourage 
regular physical activity
e. Encourage women to weigh themselves weekly 
between appointments and enter weight weekly into 
record card and check their progress according to their 
weight gain chart 
Given intervention leaflet explaining the intervention and 
encourages women to self weigh each week
Usual Care
Randomised to usual care or usual care plus the intervention
Semi structured interviews with participants (postnatally) and community midwives (once all women 
under their care in the trial have delivered) (not currently funded)
Not eligible
Planned to receive consultant led 
care at time of recruitment where 
hospital appointments are planned 
to replace community midwife care
Unable to understand English or 
provide informed consent
Attending a formal weight 
management programme 
Current severe mental illness
History of eating disorders 
Dependent on illicit drugs/alcohol
Fig. 4 Study flow diagram
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Randomisation and blinding
The telephone randomisation service at the Primary
Care Clinical Research Trials Unit (PCCRTU) will be
used to randomly allocate participants to trial groups.
The randomisation list will be developed by a statistician
within the Trials Unit using NQuery Advisor. Partici-
pants will be individually randomised to usual care plus
intervention or usual care only on a 1:1 basis using ran-
dom permuted blocks of random size. The list will be
stratified by BMI category at recruitment (healthy weight,
overweight, obese) and maternity site (Birmingham,
Oxford, Dudley & Warwick). The primary outcome is
measured by community midwives at routine 38 week
pregnancy appointments, therefore they will not be
blinded to group allocation but we have no reason to be-
lieve midwives will not record these data accurately. The
trial statistician will remain blinded to group allocation
until analysis is completed.
Intervention
No official clinical guidelines for weight gain during
pregnancy exist in the UK or in many other countries
(e.g. Australia, Ireland, Netherlands, New Zealand &
Sweden) and there are no global maternal weight gain
guidelines [23]. The only available guidelines for weight
gain during pregnancy were developed by the IOM in
the USA [4]. While we are confident the IOM guidelines
are broadly appropriate for a UK population where this
study is based, the principles of our intervention are
such that it could be used with any UK or country spe-
cific guidelines that might be subsequently adopted. The
intervention will supplement usual antenatal care. Com-
munity midwives will be asked to weigh women at each
antenatal appointment and plot their weight on an IOM
weight gain chart appropriate to their BMI at recruit-
ment. The chart will be attached to the woman’s hand
held pregnancy notes and will outline a maximum
weight gain limit for each subsequent appointment.
Women will be given brief feedback on their progress
emphasising the importance of healthy weight gain. The
intervention will actively engage women in self monitor-
ing of their weight by them recording their weekly
weight on a record chart and encouraging them to use
their weight chart to reflect on what their maximum
weight limit is for each week of pregnancy and to take
action if required.
Regular weighing and weight gain charts
All study community midwives will be issued with
calibrated light weight portable weighing scales and
instructed to use these for this study. Women will be
weighed by their midwife at each antenatal appointment.
After 12 weeks of pregnancy in usual antenatal care
there are up to eight consultations or opportunities for
the intervention to take place. The explicit behavioural
goal of the intervention will be for women’s weight gain
to follow the trajectory of the midpoint line of the
healthy weight gain zone of their IOM chart (Fig. 2a–c)
to prevent excessive weight gain. In line with NICE guid-
ance the goal will always be for weight gain, and never
weight loss. The weight gain charts are personalised ac-
cording to women’s weight and BMI category (healthy
weight, overweight, obese) at recruitment.
Many women do not know their pre pregnancy weight
therefore when the weight gain chart is prepared and
customised at recruitment it will be assumed that women
have gained average weight at recruitment in line with
weeks of gestation according to their BMI category. BMI
and therefore the BMI category weight chart used will
be based on participants’ BMI when measured at
recruitment.
Setting the parameters for gestational weight gain
The intervention will support women to stay on course
for healthy overall weight gain by setting a maximum
weight gain limit for each subsequent antenatal appoint-
ment that encourages women to stay within the two
threshold lines on their weight chart. As used in the
feasibility trial we will teach midwives a simple method
for adjusting women’s maximum weight gain limit that
aims to move women’s weight gain back to the healthy
zone, but safely and slowly (see Fig. 2a–c). Women
whose weight gain is within the appropriate range on
the chart will be told they are gaining the ideal amount
of weight and encouraged to maintain a healthy lifestyle.
Women gaining too much weight will be encouraged to
eat a healthy diet and restrict their intake of high fat and
sugary foods and drinks and to participate in regular
physical activity (walking). Women who are gaining too
little weight will be referred by their midwife to the ap-
propriate health professional in line with local practice.
As we do not want women to lose weight at any stage in
their pregnancy it may not be possible to meet the final
target if early weight gain is excessive.
Advice about gestational weight gain and lifestyle
As part of the feedback from the weight gain charts,
midwives will give messages about the importance of
preventing excessive weight gain during pregnancy, ad-
dress misconceptions about nutritional needs during
pregnancy (e.g. “eating for two”, “weight gain does not
matter when you are pregnant”, “you shouldn’t exercise
when you are pregnant”) and offer usual advice about
healthy eating and exercise in pregnancy. This is
intended as a brief intervention that could be imple-
mented into routine care, so midwives will not be ex-
pected to engage women in detailed lifestyle counselling
about how changes to diet and physical activity might be
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implemented; the focus will be on giving brief feedback
and advice. Women will be encouraged to accumulate
30 min of moderate intensity physical activity (walking)
each day in line with current recommendations [51, 52].
Brief advice about healthy eating will include portion
control, decreasing energy dense foods, limiting sugar-
sweetened beverages, increasing and/or maintaining con-
sumption of fruit and vegetables. If women are already
following a healthy lifestyle midwives will encourage con-
tinuation of these health behaviours and emphasise why it
is important to do so during pregnancy. The focus of the
intervention is on setting targets, providing feedback, and
encouraging self-monitoring. It is not on detailed nutri-
tional and exercise counselling.
Self weighing and monitoring of weight
Women will be asked to monitor weight by weighing
themselves weekly and will be reminded to do so by
their community midwife at each appointment. They
will assess their progress towards the maximum weight
gain limit set by their midwife on the weight gain chart;
this will provide women with a visual picture of their
weight gain progress to date and a prompt to take action
if they are not on target. In addition women will be
asked to write down their weight on their weight record
card and set themselves a reminder to do so between ap-
pointments with the midwife (Fig. 3). Collectively these
tasks are important for several reasons. We learnt from
our feasibility trial that we needed to place greater em-
phasis on women self managing their weight between
appointments and have established strategies to help
achieve this. There are gaps of several weeks between
some antenatal appointments (e.g. between 16–24 weeks
of pregnancy) so it is important for women to be aware
of their weight gain during these intervals, so that lapses
can be identified early and correction implemented. The
intervention seeks to encourage women to work in part-
nership with their midwife rather than relying entirely
on the midwife for feedback before taking action. We
also want women to become familiar and comfortable
with using their weight gain chart to understand what
their weight should be for each week of pregnancy.
Women who do not have scales at home will be given
some to use at recruitment. At baseline women will be
advised to check their weight when they get home on
their own scales to assess whether their home scales are
measuring the same weight as recorded by their midwife.
Women who have scales that do not record weight
accurately (within 0. 5 kg of the measured weight at re-
cruitment) will be asked to contact the study coordinat-
ing centre which will issue new scales. Women will be
encouraged to only weigh themselves once per week.
Women will be encouraged to work out when and where
they plan to weigh themselves and write down their
weight on the record card. Helping women form imple-
mentation intentions should increase adherence.
Intervention leaflet
Women randomised to the intervention will be given a
brief leaflet outlining the key principles as described here
and it will explain to women why it is important to
weigh themselves each week and check their weekly
maximum weight gain limit. Examples of how women
might implement weekly weighing (implementation in-
tentions) will also be included in the leaflet.
Training community midwives to deliver the intervention
The training module was developed for the feasibility
trial and modified based on feedback from community
midwives. It takes 60 min to deliver and is designed for
group training, with information on study eligibility cri-
teria, recruitment procedures and the importance of
adhering to protocol. It describes the intervention, in-
cluding information on the consequences of weight gain
during pregnancy, instructions about how to weigh and
plot weight on the chart, how to give feedback on the
weight gain chart and example messages, set weight gain
limits using the charts, and examples of educational and
motivational messages about gestational weight gain,
diet and physical activity during pregnancy. Midwives
will practice completing the weight gain charts using
prepared case studies. The training module will include
example cases demonstrating how the intervention
works in practice, the kind of questions likely to be
raised by women and ideas of how to deal with them.
Intervention implementation and fidelity
Early in the study we will select a random sample of 50
charts from different midwives across study sites to be
checked by the research team for completion and accur-
acy when women are 20 weeks pregnant. This will pro-
vide an indication if additional training of midwives is
required. To provide a measure of intervention imple-
mentation in the intervention group as a summary on
trial completion we will obtain participants’ weight gain
charts and weight record cards and assess accuracy.
From the weight gain chart we will check whether
weight had been measured, plotted and recorded by
community midwives and if maximum weight gain limits
were calculated and recorded correctly at each antenatal
appointment. We will assess how frequently midwives
set maximum weight targets and how often they encour-
aged women to weigh themselves weekly. We will assess
how often women in the intervention group completed
their weekly weight record to measure their engagement
with the intervention. We will assess whether midwives
delivered advice according to the protocol in the inter-
vention group and did not contaminate the trial in the
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usual care group by asking women in a questionnaire
about the advice given by their community midwife
about weight control, eating, and physical activity.
Usual care
The usual care group will receive standard maternity
care according to local health care provision and no
other intervention. NICE [42, 53] state that women
should be given information on diet and exercise early
in pregnancy. NICE [42, 53] do not currently recom-
mend that midwives routinely weigh women or give in-
formation about optimal weight gain during pregnancy.
This is not a trial about giving lifestyle advice so mid-
wives will not be asked to refrain from offering usual ad-
vice about diet and exercise early in pregnancy. This
trial is testing the addition to usual care of an interven-
tion where midwives set targets for healthy weight gain,
weigh women and encourage women to monitor their
weight to ensure they stay on target, and give feedback
on every visit for antenatal care.
Descriptive data
Data will be collected about participants’ demographic
details, smoking status and weight management history
at recruitment.
Data, outcomes and process measures
See Table 1 for a comprehensive list of the outcomes
and process measures in the study.
Baseline assessment
All trial women will be weighed by the research team
using calibrated scales and have their height measured
with excess clothing (i.e. shoes and coats) removed. The
study baseline questionnaires will also be completed
measuring anxiety and depression, physical activity and
diet quality.
Follow up
We rehearsed several strategies in our feasibility trial for
ensuring high follow up rates for our primary outcome
in this trial (>90 % obtained in our feasibility trial). Preg-
nant women are routinely seen by their midwife at
38 weeks of pregnancy and they will be weighed at this
appointment for the purpose of this study. At recruit-
ment all women will have a sticker inserted into their
hand held pregnancy notes on the page where midwives
normally record routine medical information; weight
and weeks of pregnancy will be recorded on this sticker.
Women who do not attend their 38 week appointment
will be contacted and alternative arrangements for them
to be weighed will be made. We have chosen 38 weeks
of pregnancy as the primary outcome because this time
represents nearly the end of pregnancy and only 7–10 %
of women deliver before this gestation [54], which leads
to a low rate of unavoidable loss to follow-up. As women
will see their community midwife weekly until the end
of pregnancy after 38 weeks, this provides several more
opportunities to catch up with women after 38 weeks if
women miss the 38 week appointment or the midwife
does not weigh women. As a consequence, we believe
loss to follow up will be low. At 38 weeks, the study
team will post a questionnaire to women to assess depres-
sion and anxiety, physical activity and diet quality. The
team will send one postal reminder to non responders.
Post study data collection
The weight gain charts will be retrieved from the preg-
nancy notes after women have had their baby. We do
not expect to have sufficient power within this trial to
detect statistically significant differences in maternal and
neonatal complications but these data will be obtained
from medical records at each hospital and described in
the trial reports to contribute to future meta analyses.
The following information on pregnancy will be col-
lected mode of delivery, inpatient days for the mother,
maternal ICU admission, preeclampsia, pregnancy in-
duced hypertension, gestational diabetes, maternal sep-
sis, preterm delivery, miscarriage, stillbirth, shoulder
dystocia, treatment for jaundice, admission to the neo-
natal intensive care unit (duration of stay if relevant and
Table 1 Data, outcomes and process measures
Recruitment measures
Eligible participants not consented
Number declined at booking scan
Number of participants randomised
Usual care
group
Intervention
group
Process measures X
Accuracy and completion rates of weight
chart by midwives
X
How frequently did midwives encourage
women to weight themselves weekly
X
Frequency of regular weighing by participants
as recorded on weight record cards
X
Outcomes
Weight X X
Depression and anxiety (HADS) [55] X X
Physical activity (Physical activity in pregnancy
questionnaire [56]
X X
Diet quality (Southampton food frequency
questionnaire) [57]
X X
Questions about diet and physical activity
advice midwives have given during pregnancy
X X
Maternal and neonatal complications
(obtained from electronic hospital records)
X X
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inpatient days), neonatal death and 1 and 5 min Apgar
score and neonatal sepsis. Data on infant birth weight
and gestational age at delivery will also be collected from
hospital electronic records.
Adverse and serious adverse events requiring
hospitalisation
There are several reasons to believe the intervention is
safe and will not cause adverse events. We are not test-
ing a dangerous intervention; the treatment consists of
regular weighing and feedback as part of routine ante-
natal care, along with self monitoring of weight at home,
none of which seem likely to create harm. Therefore, we
will not monitor the occurrence of all adverse events by
trial group as it will be burdensome for midwives and
participants. We will only report unexpected serious ad-
verse events and deaths to the research ethics commit-
tee. Expected serious adverse events (that will not be
reported to the ethics committee) are defined as pre-
eclampsia, gestational diabetes, stillbirth, neonatal death,
termination due to abnormality, gestational hyperten-
sion, cerebrovascular accident, myocardial infarction, pre
term delivery, termination, miscarriage, severe mental
health illness, antepartum haemorrhage, thromboembol-
ism, maternal sepsis, maternal admission to intensive
care, hysterectomy, visceral injury, neonatal admission to
the special care baby unit, neonatal infection, neonatal
respiratory distress.
Sample size
A total of 610 (305 per group) is sufficient to detect a 15
percentage points difference (45 % versus 60 %) [4–7, 39]
in the proportion who, at 38 weeks of pregnancy, exceed
the IOM guideline for gestational weight gain according
to their baseline pregnancy BMI in the intervention group
compared to usual care (90 % power, 5 % significance
level). Previous prevention trials [31, 41], have reported
between 10–25 % points difference between the propor-
tion in intervention and control groups that exceed the
IOM cut-offs for gestational weight gain, depending on
intervention intensity and the population, we have been
cautious in expecting 15 % points difference. The sample
size includes allowance for 20 % loss to follow up at
38 weeks of pregnancy. 610 participants would also be suf-
ficient to detect 1.6 kg difference in mean weight at
38 weeks of pregnancy (SD weight change of 5.5 kg from
our pilot RCT [50], 90 % power, 5 % significance level).
Statistical analysis
Baseline characteristics including age, social class, ethni-
city and parity will be presented by randomisation group
using summary statistics. The primary analysis will focus
on the proportion of women who exceed the IOM
guidelines for gestational weight gain at ~38 weeks of
pregnancy (primary outcome). The difference in these
proportions between the groups (and odds ratio) will be
calculated along with associated confidence interval
using mixed effects logistic regression modelling. The
analysis will adjust for BMI category (healthy weight, over-
weight, obese) and site (Birmingham, Dudley, Oxford,
Warwick) as fixed effects and midwife as a random effect.
Missing weight data for births occurring after 37 weeks
(excluding pregnancy loss), will be imputed using multiple
imputation. Linear mixed modelling will be used to com-
pare the secondary outcomes of weight gain per weeks of
pregnancy, depression, anxiety, physical activity and diet
recorded at ~38 weeks of pregnancy. Mother and baby
pregnancy complication rates will be summarised by
group. In a planned but exploratory subgroup analysis,
BMI categories (healthy weight, overweight, obese) will be
compared for the primary outcome by its inclusion as an
interaction term (intervention by BMI category) in the
modelling. There are no other planned subgroup analyses.
A sensitivity analysis of the primary outcome will be per-
formed without imputing missing weights. Treatment ef-
fects, 95 % confidence intervals, and two-sided p values
will be reported for all comparisons. Analyses will be
undertaken using an intention to treat approach. Full de-
tails of analysis will be pre-specified in a separate statistical
analysis plan.
Trial steering committee and data monitoring committee
A trial steering committee (TSC) will be convened to
provide overall supervision of the trial and ensure its
conduct is in accordance with the principles of Good
Clinical Practice and the relevant regulations. The TSC
will agree the trial protocol and any protocol amend-
ments. Furthermore the TSC will provide advice to the
investigators on all aspects of the trial. We do not
propose that a data monitoring and ethics committee
would be useful as this is an unblinded study with no
substantial risk and no early termination rules.
Ethical approval
The Chief Investigator has obtained favourable ethical
approval for the study from the South Birmingham
NRES Committee (14/WM/1134). The study will be con-
ducted in accordance with the recommendations for phy-
sicians involved in research on human subjects adopted
by the 18th World Medical Assembly, Helsinki 1964 and
later revisions. The University of Birmingham will act as
the sponsor. All the hospitals involved in this research
have ethically reviewed and approved the protocol.
Discussion
This study will evaluate the effectiveness of an interven-
tion to prevent excessive weight gain. This study has de-
sign strengths as well as some limitations. We have
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followed best practice in designing the randomisation
procedures and implementing concealment of allocation.
In common with practically all trials of behavioural in-
terventions, it was impossible to blind either participants
or midwives to which group they are in. However, it is
unlikely that knowledge of group allocation will particu-
larly affect other maternity care offered to women that
might prevent excessive weight gain. Midwives rarely en-
gage on this topic in routine care and part of the impact
of the intervention of weighing women, giving feedback,
and setting maximum weight gain limits is to prompt
discussion of the importance of healthy weight gain and
how to achieve it in the intervention group. In this trial,
our primary outcome is assessed by midwives who are
not blind to treatment allocation. In deciding to do this,
we faced a trade-off between participant and midwife
burden and achieving high rates of follow-up on the one
hand and between blinded follow-up on the other. We
believe that women are highly motivated to attend ma-
ternity care and are much more likely to be motivated
and able to attend for this than they would be for
blinded follow-up for weighing by a researcher. As
weight is objective, we think the risk of bias from this
compromise is low and less than the risk of attrition bias
that we judged more likely trying to implement blinded
follow-up, particularly for the control group for whom
being weighed may not seem that important. By declar-
ing our outcomes in advance and writing a detailed stat-
istical analysis plan we have protected against selective
reporting bias.
A lack of high quality trials has hindered the develop-
ment of recommendations for clinical practice in the UK
and many other countries. The proposed trial will test
an intervention that can be delivered at scale as part of
routine antenatal care incurring minimal additional
costs, using the professional expertise of community
midwives but not requiring specialist weight manage-
ment skills. Given that it is impossible to predict who
will gain excessive weight, we need interventions that
need to be applied to all women, implying that they
must be low intensity and inexpensive. If an intervention
such as this was shown to be effective, it seems likely
that it could immediately become part of routine mater-
nity care at a small cost, without increasing substantially
antenatal appointment length. Other than our pilot
RCT, this is the first trial to investigate the benefits of
setting weight limits and regular weighing by community
midwives.
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